Rm Swellcure Therapies Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
as on 09-12-2024
- Revenue 26.96%
(FY 2023)
- Profit 14.21%
(FY 2023)
- Ebitda 17.38%
(FY 2023)
- Net Worth 16.17%
(FY 2023)
- Total Assets 13.21%
(FY 2023)
About Rm Swellcure Therapies
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.50 M.
Mandeep Kandra and Sonia Kandra serve as directors at the Company.
- CIN/LLPIN
U24231DL2002PTC116930
- Company No.
116930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rm Swellcure Therapies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mandeep Kandra  | Director | 11-Sep-2002 | Current |
| Sonia Kandra | Director | 19-May-2011 | Current |
Financial Performance of Rm Swellcure Therapies.
Rm Swellcure Therapies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.96% increase. The company also saw a substantial improvement in profitability, with a 14.21% increase in profit. The company's net worth Soared by an impressive increase of 16.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rm Swellcure Therapies?
Unlock access to Rm Swellcure Therapies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Nov 2022 | ₹3.00 M | Open |
Edelweiss Finance & Investments Limited Creation Date: 20 Oct 2011 | ₹4.50 M | Open |
How Many Employees Work at Rm Swellcure Therapies?
Rm Swellcure Therapies has a workforce of 35 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rm Swellcure Therapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rm Swellcure Therapies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
